Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
Chronic hepatitis B virus (HBV) infection leads to cirrhosis and hepatocellular carcinoma (HCC). Antiviral agents are thought to reduce HCC development, but agents such as lamivudine (LAM) have a high rate of drug resistance. We compared the incidence of HCC in 472 entecavir (ETV)-treated patients a...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | angličtina |
| Vydáno: |
2012
|
| On-line přístup: | https://doi.org/10.1002/hep.26180 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.26180 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|